COFOE MEDICAL logo

COFOE MEDICAL

01187 · HKEX
Vermeld

The company is committed to providing users with lifelong, trusted medical and health products and one-stop solutions, covering five major areas: health monitoring, rehabilitation assistive devices, r…

Vermeld

IPO-tijdlijn

  1. OpenenApr 27
  2. SluitenApr 30
  3. ToezeggingMay 05
  4. BetalingMay 06
  5. LijstMay 06

Kerngegevens

Uitgifteprijs

HKD 39.33

Min. inschrijfkosten

HKD 3,972.66

Uitgegeven aandelen

27.00M

Lotgrootte

100

Totale verhoging

HKD 1061.9M

Geschatte marktplafond

—

Overheidstoewijzing

10.0%

Internationale plaatsing

90.0%

Bedrijfsoverzicht

The company is committed to providing users with lifelong, trusted medical and health products and one-stop solutions, covering five major areas: health monitoring, rehabilitation assistive devices, respiratory support, medical nursing, and traditional Chinese medicine physiotherapy.

Gebruik van opbrengsten

1、30.0%​ (approx. HK$302.1 million) for global expansion;

2、30.0%​ (approx. HK$302.1 million) for continuous product R&D and technological innovation, including artificial intelligence (AI) and Internet of Things (IoT) applications;

3、20.0%​ (approx. HK$201.4 million) for expanding our domestic sales channels and distribution network;

4、10.0%​ (approx. HK$100.7 million) for brand promotion and marketing campaigns;

5、10.0%​ (approx. HK$100.7 million) for working capital and general corporate purposes.

Sponsor Track record

Track-record gegevens worden vernieuwd.

Bemiddelaars en documenten

Sponsors

  • 華泰金融控股(香港)有限公司
  • 法國巴黎證券(亞洲)有限公司

Underwriters

  • 華泰金融控股(香港)有限公司
  • 法國巴黎證券(亞洲)有限公司
  • 富途證券國際(香港)有限公司

Prospectus PDF

Prospectus PDF →

Hoeksteenbeleggers

  • 蓝思科技(香港)有限公司
  • 长沙雨丰科技有限公司
  • 远信投资及中国银河国际投资
  • 盘京港景投资基金
  • 黄雪林
  • FR M CONSULTING CO., LTD
  • 戴钧安
  • 香港汉清达实业有限公司
  • 中康科技控股有限公司
  • 陆勤超
  • 大成国际资产管理有限公司
  • ODI TRUST LIMITED

Total

0

35.7% of placement

BBX neemt niet deel aan het toewijzingsproces voor een IPO die op deze pagina wordt vermeld. Deze pagina is uitsluitend ter informatie en is geen beleggingsadvies.